Intro offer
100 days of Premium for just $10.
Try all Premium features for over 3 months and analyze stocks without limits.
Try 100 days for $10

$35.08
0.09%
Nasdaq, Sep 16, 02:15 pm EDT. Market open.
ISIN
US79957L1008
Symbol
SMTI

Sanara MedTech Inc Target price 2026 - Analyst rating & recommendation

Sanara MedTech Inc Classifications & Recommendation

Hold
63%
Sell
38%

Sanara MedTech Inc Price Target

Target Price $35.70
Price $35.11
Potential
Number of Estimates 5
5 Analysts have issued a price target Sanara MedTech Inc 2027 . The average Sanara MedTech Inc target price is $35.70. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 0 Analysts recommend Sanara MedTech Inc to buy, 5 to hold and 3 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Sanara MedTech Inc stock has an average upside potential 2027 of . Most analysts recommend the Sanara MedTech Inc stock at Hold.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 103.12 119.31
18.98% 15.70%
EBITDA Margin 11.45% 15.86%
103.82% 38.48%
Net Margin -36.42% 1.49%
226.79% 104.09%

5 Analysts have issued a sales forecast Sanara MedTech Inc 2026 . The average Sanara MedTech Inc sales estimate is

$119m
unlock
. This is
8.65% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$125m 13.40%
unlock
, the lowest is
$113m 2.90%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $103m 18.98%
2026
$119m 15.70%
unlock
2027
$135m 13.02%
unlock
2028
$152m 12.48%
unlock
2029
$173m 14.33%
unlock
2030
$193m 11.18%
unlock

4 Analysts have issued an Sanara MedTech Inc EBITDA forecast 2026. The average Sanara MedTech Inc EBITDA estimate is

$18.9m
unlock
. This is
73.59% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$19.5m 79.17%
unlock
, the lowest is
$18.1m 66.33%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $11.8m 142.51%
2026
$18.9m 60.21%
unlock
2027
$20.7m 9.16%
unlock
2028
$23.2m 12.10%
unlock
2029
$25.5m 10.13%
unlock
2030
$27.5m 8.00%
unlock

EBITDA Margin

2025 11.45% 103.82%
2026
15.86% 38.48%
unlock
2027
15.32% 3.40%
unlock
2028
15.27% 0.33%
unlock
2029
14.71% 3.67%
unlock
2030
14.29% 2.86%
unlock

5 Sanara MedTech Inc Analysts have issued a net profit forecast 2026. The average Sanara MedTech Inc net profit estimate is

$1.8m
unlock
. This is
105.56% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$2.0m 106.34%
unlock
, the lowest is
$1.4m 104.50%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-37.6m 288.82%
2026
$1.8m 104.74%
unlock
2027
$7.0m 294.94%
unlock
2028
$8.3m 18.63%
unlock

Net Margin

2025 -36.42% 226.79%
2026
1.49% 104.09%
unlock
2027
5.21% 249.66%
unlock
2028
5.50% 5.57%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -4.35 0.19
284.96% 104.37%
P/E 181.17
EV/Sales 2.96

5 Analysts have issued a Sanara MedTech Inc forecast for earnings per share. The average Sanara MedTech Inc EPS is

$0.19
unlock
. This is
105.15% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$0.22 105.96%
unlock
, the lowest is
$0.16 104.34%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-4.35 284.96%
2026
$0.19 104.37%
unlock
2027
$0.77 305.26%
unlock
2028
$0.91 18.18%
unlock

P/E ratio

Current -9.51 67.50%
2026
181.17 2,004.07%
unlock
2027
45.90 74.66%
unlock
2028
38.68 15.73%
unlock

Based on analysts' sales estimates for 2026, the Sanara MedTech Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.22 4.73%
2026
2.96 7.95%
unlock
2027
2.62 11.52%
unlock
2028
2.33 11.10%
unlock
2029
2.04 12.53%
unlock
2030
1.83 10.05%
unlock

P/S ratio

Current 2.94 5.35%
2026
2.70 7.96%
unlock
2027
2.39 11.52%
unlock
2028
2.13 11.10%
unlock
2029
1.86 12.53%
unlock
2030
1.67 10.05%
unlock

Current Sanara MedTech Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HC Wainwright & Co.
Locked
Locked
Locked Jul 30 2026
Freedom Broker
Locked
Locked
Locked Jun 17 2026
Lake Street
Locked
Locked
Locked Apr 15 2026
HC Wainwright & Co.
Locked
Locked
Locked Jan 26 2026
HC Wainwright & Co.
Locked
Locked
Locked Nov 14 2025
HC Wainwright & Co.
Locked
Locked
Locked Aug 18 2025
HC Wainwright & Co.
Locked
Locked
Locked May 15 2025
Analyst Rating Date
Locked
HC Wainwright & Co.:
Locked
Locked
Jul 30 2026
Locked
Freedom Broker:
Locked
Locked
Jun 17 2026
Locked
Lake Street:
Locked
Locked
Apr 15 2026
Locked
HC Wainwright & Co.:
Locked
Locked
Jan 26 2026
Locked
HC Wainwright & Co.:
Locked
Locked
Nov 14 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Aug 18 2025
Locked
HC Wainwright & Co.:
Locked
Locked
May 15 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today